CEO Emma Walmsley is confident in delivering growth commitme...
CEO Emma Walmsley is confident in delivering growth commitments and progressing with innovation in core therapy areas. Strong performance of Arexvy and potential expansion of its approval could be positive for GSK's future.
GSK Reports Earnings Wednesday. Investors Are Watching the RSV Vaccine Showdown. -- Barrons.com
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3395Followers
0Following
8184Visitors
Follow